which glp 1 drugs are approved for obesity GLP-1 Medications Infographic Indications for GLP-1/GIP RA Summary

Description

Contact your GP or healthcare provider if you experience: Severe or worsening joint pain that interferes with daily activities or does not improve with simple measures Joint swelling, redness, or warmth , which may indicate inflammation or infection Sudden onset of intense pain in a single joint, particularly if accompanied by fever (may require same-day assessment to exclude septic arthritis or gout) Joint pain associated with systemic symptoms such as unexplained fever, weight loss (beyond expected treatment effects), rash, or general malaise Persistent pain lasting more than two weeks despite self-care measures Joint stiffness lasting more than 30 minutes after waking , which may suggest inflammatory arthritis Reduced range of motion or inability to bear weight on affected joints Seek urgent medical attention (contact 111 or attend A&E) if: Joint pain is accompanied by severe abdominal pain, persistent vomiting, or signs of pancreatitis (if pancreatitis is suspected, stop your GLP-1 medication immediately

Trulicity is an injectable medication taken under the skin in the stomach area (abdomen), upper leg (thigh), or upper arm per the instructions of a healthcare provider

At 12 mg, 86% of participants achieved normal liver fat, defined as below 5%, versus 0% in the placebo arm

By reducing neuroinflammation from both the metabolic and the alcohol-related sides, these medications may break the self-reinforcing cycle where inflammation drives consumption, and consumption drives more inflammation